Gemcitabin装载金属有机框架纳米粒子与粒子治疗的协同效应
Pauline Maury1, Ryoichi Hirayama2, Xue Li3
1Université Paris Saclay, CNRS, Institut des Sciences Moléculaires d'Orsay (ISMO), 91405 Orsay, France; Université Paris-Saclay, Gustave Roussy, Inserm U1030, Radiothérapie Moléculaire et Innovation Thérapeutique, F-94800, Villejuif, France; Gustave Roussy, Département de radiothérapie, F-94800, Villejuif, France.
International journal of pharmaceutics
|September 18, 2024
概括
这项研究将纳米金属有机框架 (nanoMOFs) 与粒子疗法相结合,用于增强癌症治疗. 纳米MOFs提供吉米他单酸盐 (GemMP),改善对缺氧瘤的疗效,并减少辐射剂量.
科学领域:
- 纳米医学是一种纳米医学.
- 辐射疗法 辐射疗法
- 药物输送系统 药物输送系统
背景情况:
- 使用纳米剂和辐射的组合疗法可以改善癌症治疗.
- 缺氧和瘤微环境是放射治疗的主要障碍.
- 颗粒疗法提供了精确的向和比传统放射疗法更高的疗效.
研究的目的:
- 为了研究多孔金属有机框架 (nanoMOFs) 的有效性,加载了结合颗粒疗法的吉米他单酸盐 (GemMP).
- 评估缺氧对这种新型放射化疗策略的影响.
- 评估纳米MOFs克服生物障碍和有效提供药物的能力.
主要方法:
- 在多孔金属有机框架 (纳米MOF) 中加载金胺单酸盐 (GemMP).
- 将装有GemMP的纳米MOF与粒子治疗 (碳或离子) 结合起来.
- 在正常 (20% pO2) 和低氧 (0.5% pO2) 条件下测试疗效.
- 量化协同效应和纳米粒子通过细胞外基质的透.
主要成果:
- 装有GemMP的纳米MOF在正常和缺氧条件下显著提高颗粒疗法的抗癌疗效.
- 照射剂量减少了1.4倍在诺摩西亚和1.6倍在低氧达到相同的细胞毒性作用.
- 观察并量化了GemMP装载的纳米MOF和粒子治疗之间的协同效应.
- 纳米MOFs通过细胞外基质和细胞积累表现出扩散,封装的GemMP显示出比免费药物更高的疗效.
结论:
- 装有GemMP的纳米MOF与颗粒疗法相结合,代表了一个有前途的放射化疗策略.
- 这种方法有效地提高了抗癌疗效,特别是在缺氧瘤中.
- 纳米MOF作为有效的药物载体,克服生物障碍并改善治疗结果.
- 这种"全合一"纳米药物设计最大限度地提高了对瘤的细胞毒性作用,同时最大限度地降低了对健康组织的毒性.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K